journal article·2018

A novel self-assembled pH-sensitive targeted nanoparticle platform based on antibody–4arm-polyethylene glycol–pterostilbene conjugates for co-delivery of anticancer drugs

Ke-Feng Liu, Yan-Xue Liu, Lin Dai, Chun-Xiao Li, Luying Wang, Jing Liu, Jian-Du Lei

Publisher page

Abstract

Recently, antibody-drug conjugates (ADC) have shown potential for cancer immunotherapy by tumor-targeted delivery of anticancer drugs. However, the development of ADC is subject to many restrictions, such as the payloads, stabilities and intracellular uptake of the drugs, which has greatly restricted their clinical application. To overcome these hurdles, in this study, a novel pH-sensitive targeted nanoparticle platform based on a newly synthesized amphipathic antibody-drug conjugate (antibody-4arm-polyethylene glycol-pterostilbene, mAb-4arm-PEG-PS) was fabricated for co-delivery of another anticancer drug (10-hydroxy camptothecin, HCPT). The prepared mAb-4arm-PEG-PS/HCPT nanoparticles (NPs) had a moderate particle size (∼120 nm), a high drug to antibody ratio (∼22.4) and relatively high binary drug loading capacity (∼24.2 wt% HCPT, ∼2.9 wt% PS). Moreover, the mAb-4arm-PEG-PS/HCPT NPs exhibited enhanced intracellular uptake (∼5 fold that of mAb-4arm-PEG-PS conjugates) and excellent cytotoxicity in vitro. In subsequent Daudi lymphoma xenograft assays, compared with free drugs and mAb-4arm-PEG-PS conjugates, the mAb-4arm-PEG-PS/HCPT NPs inhibited tumor growth more efficiently. Our results indicated the great potential of mAb-4arm-PEG-PS/HCPT NPs for targeted co-delivery of anticancer drugs to solid tumors.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: HER2/EGFR in Cancer Research · Monoclonal and Polyclonal Antibodies Research · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Beijing Key Laboratory of Lignocellulosic Chemistry

Beijing Forestry University

Beijing 100083

P. R. China

Tianjin Key Laboratory of Marine Resources and Chemistry

Tianjin University of Science and Technology

Tianjin

China

Funding

National Natural Science Foundation of China · Tianjin University of Science and Technology

References (32)

Show source-provided references
1. Chari · Angew. Chem., Int. Ed. · 2014 · 53 · 379610.1002/anie.201307628 ↗
2. Zolot · Nat. Rev. Drug Discovery · 2013 · 12 · 25910.1038/nrd3980 ↗
3. Perez · Drug Discovery Today · 2014 · 19 · 86910.1016/j.drudis.2013.11.004 ↗
4. Senter · Nat. Biotechnol. · 2012 · 30 · 63110.1038/nbt.2289 ↗
5. Verma · N. Engl. J. Med. · 2012 · 367 · 178310.1056/NEJMoa1209124 ↗
6. Katz · Clin. Cancer Res. · 2011 · 17 · 642810.1158/1078-0432.CCR-11-0488 ↗
7. Anderl · Antibody–Drug Conjugates · 2013 · 5110.1007/978-1-62703-541-5_4 ↗
8. Mcdonagh · Protein Eng., Des. Sel. · 2006 · 19 · 29910.1093/protein/gzl013 ↗
9. Hamblett · Clin. Cancer Res. · 2004 · 10 · 706310.1158/1078-0432.CCR-04-0789 ↗
10. Alley · Curr. Opin. Chem. Biol. · 2010 · 14 · 52910.1016/j.cbpa.2010.06.170 ↗
11. Ducry · Bioconjugate Chem. · 2009 · 21 · 510.1021/bc9002019 ↗
12. Shen · Nat. Biotechnol. · 2012 · 30 · 18410.1038/nbt.2108 ↗
13. McCormack · J. Surg. Res. · 2012 · 173 · e5310.1016/j.jss.2011.09.054 ↗
14. Kunimoto · Cancer Res. · 1987 · 47 · 5944
15. Tacar · J. Pharm. Pharmacol. · 2013 · 65 · 15710.1111/j.2042-7158.2012.01567.x ↗
16. Trail · Antibodies · 2013 · 2 · 11310.3390/antib2010113 ↗
17. Chari · Cancer Res. · 1992 · 52 · 127
18. Hamann · Bioconjugate Chem. · 2002 · 13 · 4710.1021/bc010021y ↗
19. Yurkovetskiy · Cancer Res. · 2015 · 75 · 336510.1158/0008-5472.CAN-15-0129 ↗
20. Lyon · Nat. Biotechnol. · 2015 · 33 · 73310.1038/nbt.3212 ↗
21. Gupta · Chem. Sci. · 2017 · 8 · 238710.1039/C6SC05149A ↗
22. Elsabahy · Chem. Soc. Rev. · 2012 · 41 · 254510.1039/c2cs15327k ↗
23. Maeda · Adv. Drug Delivery Rev. · 2013 · 65 · 7110.1016/j.addr.2012.10.002 ↗
24. Perche · J. Controlled Release · 2012 · 164 · 9510.1016/j.jconrel.2012.09.003 ↗
25. Ahn · Biomaterials · 2015 · 39 · 2310.1016/j.biomaterials.2014.10.069 ↗
26. Kocbek · J. Controlled Release · 2007 · 120 · 1810.1016/j.jconrel.2007.03.012 ↗
27. Dai · J. Mater. Chem. B · 2015 · 3 · 660510.1039/C5TB00900F ↗
28. Liu · RSC Adv. · 2015 · 5 · 5159210.1039/C5RA06253E ↗
29. Shen · J. Am. Chem. Soc. · 2010 · 132 · 425910.1021/ja909475m ↗
30. D’Souza · AAPS PharmSciTech · 2005 · 6 · E32310.1208/pt060242 ↗
31. Lee · Biomaterials · 2009 · 30 · 91910.1016/j.biomaterials.2008.10.062 ↗
32. Marupudi · Expert Opin. Drug Saf. · 2007 · 6 · 60910.1517/14740338.6.5.609 ↗